Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis ((DECIDE)) ClinicalTrials.gov, 12 Sep 2013 Accessed on 19 Jun 2014 from http://www.clinicaltrials.gov/ct2/show/NCT01064401. CommentRecommendBookmarkWatch
